rs8139532

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_002133.3(HMOX1):c.144+349G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.154 (AC=23,357) in the gnomAD database across 152,146 control chromosomes, including 3,755 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.407. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 3755 hom., cov: 31)

Consequence

HMOX1
NM_002133.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.612

Publications

3 publications found
Variant links:
Genes affected
HMOX1 (HGNC:5013): (heme oxygenase 1) Heme oxygenase, an essential enzyme in heme catabolism, cleaves heme to form biliverdin, which is subsequently converted to bilirubin by biliverdin reductase, and carbon monoxide, a putative neurotransmitter. Heme oxygenase activity is induced by its substrate heme and by various nonheme substances. Heme oxygenase occurs as 2 isozymes, an inducible heme oxygenase-1 and a constitutive heme oxygenase-2. HMOX1 and HMOX2 belong to the heme oxygenase family. [provided by RefSeq, Jul 2008]
HMOX1 Gene-Disease associations (from GenCC):
  • heme oxygenase 1 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • chronic obstructive pulmonary disease
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002133.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.4067 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_002133.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

HMOX1 NM_002133.3
MANE Select
HGVSc / HGVSpc.144+349G>A
Exon rankIntron 2 of 4
intron
Prot: NP_002124.1UniProt: P09601Q6FH11

Ensembl Transcripts

HMOX1 ENST00000216117.9
TSL:1MANE Select
HGVSc / HGVSpc.144+349G>A
Exon rankIntron 2 of 4
intron
Prot: ENSP00000216117.8UniProt: P09601
HMOX1 ENST00000679074.1
HGVSc / HGVSpc.144+349G>A
Exon rankIntron 2 of 3
intron
Prot: ENSP00000503459.1UniProt: A0A7I2V3I1
HMOX1 ENST00000412893.5
TSL:3
HGVSc / HGVSpc.144+349G>A
Exon rankIntron 3 of 3
intron
Prot: ENSP00000413316.1UniProt: B1AHA8

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.153
AC:23311
Hom:3751
AN:152028
Cov:31
GnomAD4 genome
AF: 0.154
AC:23357
Hom:3755
AN:152146
Cov:31
TOPMed (Bravo)
AF: 0.170
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.118
AC:5869
Hom:839
AN:49538
Local & regional cohorts 9 sources
ABraOM SABE-WGS-1171
AF: 0.133
AC:312
Hom:37
AN:2342
ChinaMAP Phase 1
AF: 0.0508
Denmark Genome
AF: 0.0567
AC:17
AN:300
GenomeAsia100K
AF: 0.0940
AC:331
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0480
AC:347
AN:7234
Qatari Genome
AF: 0.159
AC:28
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0471
AC:5777
Hom:133
AN:122692
Turkish Variome
AF: 0.0776
AC:120
Hom:4
AN:1546
UK10K
AF: 0.0558
AC:422
AN:7562
Showing 13 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain14
BayesDel_noAF
Benign-0.86
CADD
Benign13
DANN
Benign0.78
GPN-Star LLR
N/A0.27
GPN-Star score
N/A-0.27
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign0.61
PromoterAI
N/A-0.036Neutral
Showing 9 of 9 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.